Incidence and determinants of tuberculosis among HIV-positive individuals in Addis Ababa, Ethiopia: A retrospective cohort study

Objective: To assess the incidence and determinants of tuberculosis (TB) among HIV-positive individuals in selected health facilities of Addis Ababa, Ethiopia, during the period January 2013 to December 2018. Methods: Data were collected from the records of 566 HIV-positive individuals. A retrospect...

Full description

Bibliographic Details
Main Authors: Ayinalem Alemu, Aman Yesuf, Betselot Zerihun, Melak Getu, Teshager Worku, Zebenay Workneh Bitew
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220301120
Description
Summary:Objective: To assess the incidence and determinants of tuberculosis (TB) among HIV-positive individuals in selected health facilities of Addis Ababa, Ethiopia, during the period January 2013 to December 2018. Methods: Data were collected from the records of 566 HIV-positive individuals. A retrospective cohort study design was employed. Data were entered into Epi Info 7 and analyzed using IBM SPSS Statistics version 20. TB incidence density was determined per 100 person-years. Time-to-event distributions were estimated using Kaplan–Meier estimates. Survival curves and hazards across different categories were compared using log-rank tests. Determinants were identified using the Cox proportional hazards model. The hazard ratio (HR) and 95% confidence interval (CI) were computed. A p-value <0.05 in the multivariate analysis was considered statistically significant. Results: A total of 566 HIV-positive individuals were followed for 2140.08 person-years, giving a TB incidence density rate of 6.82/100 person-years (146, 25.8%). The highest incidence was observed within the first year of follow-up. Independent determinants were large family size (adjusted HR (AHR) 1.783, 95% CI 1.113–2.855), lower baseline CD4 (AHR 2.568, 95% CI 1.602–4.116), and baseline body mass index <18.5 kg/m2 (AHR 1.907, 95% CI 1.530–2.690). Being enrolled in antiretroviral treatment (AHR 0.066, 95% CI 0.045–0.98) and taking isoniazid prophylaxis treatment (AHR 0.202, 95% CI 0.108–0.380) had a protective effect. Conclusions: TB is still a major cause of morbidity among HIV-positive individuals. Early HIV diagnosis, enrollment on antiretroviral treatment, and isoniazid prophylaxis treatment should be considered to decrease the TB risk.
ISSN:1201-9712